• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
OTC Pharmaceuticals in United Arab Emirates - Product Image

OTC Pharmaceuticals in United Arab Emirates

  • Published: August 2013
  • Region: United Arab Emirates
  • 35 pages
  • MarketLine

Introduction

OTC Pharmaceuticals in United Arab Emirates industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United Arab Emirates otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic READ MORE >

Executive Summary
Market value
Market value forecast
Category segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
GlaxoSmithKline Plc
Johnson & Johnson
Novartis AG
WellSpring Pharmaceuticals
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research

LIST OF TABLES
Table 1: United Arab Emirates OTC pharmaceuticals market value: $ million, 2008–12
Table 2: United Arab Emirates OTC pharmaceuticals market category segmentation: $ million, 2012
Table 3: United Arab Emirates OTC pharmaceuticals market share: % share, by value, 2012
Table 4: United Arab Emirates OTC pharmaceuticals market distribution: % share, by value, 2012
Table 5: United Arab Emirates OTC pharmaceuticals market value forecast: $ million, 2012–17
Table 6: GlaxoSmithKline Plc: key facts
Table 7: GlaxoSmithKline Plc: key financials ($)
Table 8: GlaxoSmithKline Plc: key financials (£)
Table 9: GlaxoSmithKline Plc: key financial ratios
Table 10: Johnson & Johnson: key facts
Table 11: Johnson & Johnson: key financials ($)
Table 12: Johnson & Johnson: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: WellSpring Pharmaceuticals : key facts
Table 17: United Arab Emirates size of population (million), 2008–12
Table 18: United Arab Emirates gdp (constant 2000 prices, $ billion), 2008–12
Table 19: United Arab Emirates gdp (current prices, $ billion), 2008–12
Table 20: United Arab Emirates inflation, 2008–12
Table 21: United Arab Emirates consumer price index (absolute), 2008–12
Table 22: United Arab Emirates exchange rate, 2008–12

LIST OF FIGURES
Figure 1: United Arab Emirates OTC pharmaceuticals market value: $ million, 2008–12
Figure 2: United Arab Emirates OTC pharmaceuticals market category segmentation: % share, by value, 2012
Figure 3: United Arab Emirates OTC pharmaceuticals market share: % share, by value, 2012
Figure 4: United Arab Emirates OTC pharmaceuticals market distribution: % share, by value, 2012
Figure 5: United Arab Emirates OTC pharmaceuticals market value forecast: $ million, 2012–17
Figure 6: Forces driving competition in the OTC pharmaceuticals market in United Arab Emirates, 2012
Figure 7: Drivers of buyer power in the OTC pharmaceuticals market in United Arab Emirates, 2012
Figure 8: Drivers of supplier power in the OTC pharmaceuticals market in United Arab Emirates, 2012
Figure 9: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in United Arab Emirates, 2012
Figure 10: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in United Arab Emirates, 2012
Figure 11: Drivers of degree of rivalry in the OTC pharmaceuticals market in United Arab Emirates, 2012
Figure 12: GlaxoSmithKline Plc: revenues & profitability
Figure 13: GlaxoSmithKline Plc: assets & liabilities
Figure 14: Johnson & Johnson: revenues & profitability
Figure 15: Johnson & Johnson: assets & liabilities
Figure 16: Novartis AG: revenues & profitability
Figure 17: Novartis AG: assets & liabilities

GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG and WellSpring Pharmaceuticals

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos